KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,274,000 | +947.9% | 28,966 | +498.2% | 0.08% | +1420.0% |
| Q4 2016 | $217,000 | -12.5% | 4,842 | +9.2% | 0.01% | +25.0% |
| Q3 2016 | $248,000 | -76.8% | 4,433 | -79.2% | 0.00% | -77.8% |
| Q2 2016 | $1,067,000 | +246.4% | 21,333 | +285.1% | 0.02% | +500.0% |
| Q3 2015 | $308,000 | +44.6% | 5,540 | +58.3% | 0.00% | +50.0% |
| Q2 2015 | $213,000 | -86.2% | 3,500 | -86.9% | 0.00% | -86.7% |
| Q1 2015 | $1,541,000 | – | 26,708 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |